Growth-oriented investor and operating executive with experience advising and scaling healthcare and technology companies, focused on revenue growth, commercial strategy and board-level governance. Erin Colleen Ross brings cross-functional operating leadership, capital-raising experience and strategic M&A involvement to portfolio companies, often partnering with PE and venture investors to drive exits. Prior roles span corporate development, product-led commercialization and investor relations; education and early career combine business and sector-specific expertise. Market-facing profile emphasizes operational value creation, board oversight and transaction execution for growth-stage businesses.
Growth-oriented investor and operating executive with experience advising and scaling healthcare and technology companies, focused on revenue growth, commercial strategy and board-level governance. Erin Colleen Ross brings cross-functional operating leadership, capital-raising experience and strategic M&A involvement to portfolio companies, often partnering with PE and venture investors to drive exits. Prior roles span corporate development, product-led commercialization and investor relations; education and early career combine business and sector-specific expertise. Market-facing profile emphasizes operational value creation, board oversight and transaction execution for growth-stage businesses.
Growth-stage, operations-first investor prioritizing revenue acceleration and commercial scale; targets healthcare and tech businesses where product-market fit can be amplified through go-to-market, pricing, and strategic partnerships. Capital allocation favors minority growth equity and board-active positions alongside PE/VC sponsors, emphasizing short-to-medium horizons to exit via strategic sale or recap. Underwriting blends commercial metrics, governance readiness and M&A optionality; risk managed via staged capital, KPI-driven milestones and operator-led value creation.
Growth-stage, operations-first investor prioritizing revenue acceleration and commercial scale; targets healthcare and tech businesses where product-market fit can be amplified through go-to-market, pricing, and strategic partnerships. Capital allocation favors minority growth equity and board-active positions alongside PE/VC sponsors, emphasizing short-to-medium horizons to exit via strategic sale or recap. Underwriting blends commercial metrics, governance readiness and M&A optionality; risk managed via staged capital, KPI-driven milestones and operator-led value creation.
| Trades 137 | Longs Won 79/137 57% | Profit Factor 110.76 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $311.4M |
| Average Win $47.18M | Best Trade (Mar 30) $3.65B | Sharpe Ratio -4.91 |
| Average Loss -$580,145.24 | Worst Trade (Mar 30) -$7.51M | Z-Score 2.74 (99.39%) |
| Commissions $0 | Avg. Trade Length 6m 2w | Expectancy $26.96M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 55.72% | 66.44% | 73.65% | 79.24% | 83.86% | 87.83% | 91.34% | 94.49% | 97.36% |
| Consecutive Losing Trades | 1,086 | 977 | 869 | 760 | 651 | 543 | 434 | 326 | 217 | 109 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 3,000 | $868,080 | $917,790 | - | $49,710 | 5.73% | +0.219% |
ACWI iShares MSCI ACWI ETF | 385,076 | $49.54M | $62.49M | - | $12.95M | 26.14% | -0.117% |
AES AES Corporation | 1.23M | $17.98M | $18.07M | - | $85,866.94 | 0.48% | 0.0 |
AMZN Amazon.com Inc | 9,500 | $2.08M | $2.5M | - | $410,969.9 | 19.72% | -0.935% |
AXP American Express Company | 2,000 | $640,730 | $684,960.02 | - | $44,230.02 | 6.9% | -0.34% |
BBJP JPMorgan BetaBuilders Japan Fund | 60,343 | $3.42M | $4.78M | - | $1.36M | 39.67% | -0.302% |
BLD TopBuild Corp | 37,136 | $15.22M | $13.17M | - | -$2.05M | -13.5% | -1.454% |
BRK-B Berkshire Hathaway Inc. | 15,000 | $6.9M | $7.56M | - | $664,680 | 9.64% | -0.572% |
COF Capital One Financial Corporation | 3,833 | $815,509.06 | $871,394.22 | - | $55,885.16 | 6.85% | +1.568% |
D Dominion Energy, Inc. | 150,000 | $10.24M | $10.32M | - | $72,000 | 0.7% | +0.336% |
EA Electronic Arts Inc. | 39,412 | $8.08M | $8.26M | - | $183,660.4 | 2.27% | 0.0 |
EWJ iShares MSCI Japan ETF | 4,000 | $268,400 | $392,840 | - | $124,440 | 46.36% | -0.264% |
FLL Full House Resorts Inc. | 61,375 | $147,856 | $136,866.25 | - | -$10,989.75 | -7.43% | -3.043% |
GS The Goldman Sachs Group, Inc. | 1,000 | $845,990 | $1.04M | - | $193,430.04 | 22.86% | -0.308% |
GTLS Chart Industries Inc. | 285,399 | $58.41M | $59.91M | - | $1.49M | 2.55% | -0.005% |
IEUR iShares Core MSCI Europe ETF | 55,000 | $2.97M | $4.3M | - | $1.33M | 44.94% | +0.026% |
IVE ISHARES S&P 500 VALUE ETF | 5,000 | $954,400 | $1.19M | - | $236,049.98 | 24.73% | +0.034% |
JPM JPMorgan Chase & Co. | 2,000 | $588,320 | $725,680 | - | $137,360 | 23.35% | -0.074% |
KVUE Kenvue Inc. | 3.01M | $54.78M | $57.7M | - | $2.91M | 5.31% | 0.0 |
MS Morgan Stanley | 4,000 | $658,280 | $869,440 | - | $211,160 | 32.08% | -0.467% |